| Literature DB >> 28725421 |
G Ström1, M Halje1, D Karlsson1, J Jiwakanon2, M Pringle3, L-L Fernström4, U Magnusson1.
Abstract
BACKGROUND: Intensification of livestock production seen in many low- and middle-income countries is often believed to be associated with increased use of antimicrobials, and may hence contribute to the emergence of antimicrobial resistance. The aim of this study was to map antimicrobial use on small- (n = 25) and medium-scale (n = 27) pig farms in north-eastern Thailand, and to compare antimicrobial susceptibility of commensal Escherichia coli isolated from sows on these farms.Entities:
Keywords: Antimicrobial resistance; Antimicrobial use; E. coli; Farm size; Pig production; Thailand
Year: 2017 PMID: 28725421 PMCID: PMC5512823 DOI: 10.1186/s13756-017-0233-9
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Practices related to use and access to antimicrobials on the small- and medium-scale pig farms
| Small-scale % ( | Medium-scale % ( | |
|---|---|---|
| Antimicrobials injected for disease treatment | 100 (25) | 100 (27) |
| Antimicrobials added to, or included in, feeda | 4 (1) | 100 (27) |
| Person who decides on when to give antimicrobials | ||
| Farmer | 68 (17) | 0 (0) |
| Veterinarian | 32 (8) | 100 (27) |
| Source of antimicrobials | ||
| From veterinarian | 32 (8) | 0 (0) |
| From local store/pharmacy | 60 (15) | 0 (0) |
| From the contracting company | 4 (1) | 96 (26) |
| Other | 4 (1) | 4 (1) |
aOn regular basis
Antimicrobials administered to sows on the small- (n = 21a) and medium-scale farms (n = 27)
| Antimicrobials | Small-scalea | Medium-scale | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Penicillin Gb | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||
| Streptomycinb | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||
| Amoxicillinb | ● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||
| Oxytetracycline | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||
| Cefotaximeb | ● | |||||||||||||||||||||||||||||||||||||||||||||||
| Enrofloxacin | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||
| Kanamycinb | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||||||||||
| Florfenicol | ||||||||||||||||||||||||||||||||||||||||||||||||
| Gentamicinb | ● | |||||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Amoxicillinb | ● | ● | ||||||||||||||||||||||||||||||||||||||||||||||
| Colistinb | ● | |||||||||||||||||||||||||||||||||||||||||||||||
| Kitasamycin | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ||||||||||||||||||||||||||||||||||
| Oxytetracycline | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | |||||||||||||||||||||||||||||||||||
| Sulfonamide | ● | |||||||||||||||||||||||||||||||||||||||||||||||
| Farm no | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 |
aFrom four of the small-scale farms, information on which antimicrobials that were used was not obtained and these farms are thus not displayed in the figure
bAntimicrobial considered to be critically important for human medicine according to WHO [22]
Resistance and distributions of Minimum Inhibitory Concentrations (MIC) for E. coli isolates from small-scale farms
White fields denote range of dilutions tested for each substance. MICs higher than the highest concentration tested are given as the concentration closest above the range. MICs equal to or lower than the lowest concentration tested are presented underlined. The ECOFF [16] for each substance is presented as a vertical line
Resistance and distributions of Minimum Inhibitory Concentrations (MIC) for E. coli isolates from medium-scale farms
White fields denote range of dilutions tested for each substance. MICs higher than the highest concentration tested are given as the concentration closest above the range. MICs equal to or lower than the lowest concentration tested are presented underlined. The ECOFF [16] for each substance is presented as a vertical line
Antimicrobial resistance parameters of E. coli isolates from pigs on the small- and medium-scale farms
| Antimicrobial | Resistant isolates % (n) |
| OR (95% CI)a | |
|---|---|---|---|---|
| Small-scale ( | Medium-scale ( | |||
| Ciprofloxacin† | 41 (28) | 48 (39) | 0.54 | |
| Nalidixic acid† | 20 (14) | 31 (25) | 0.21 | |
| Gentamicin† | 11 (8) | 7 (6) | 0.39 | |
| Streptomycin† | 38 (26) | 77 (62) | <0.001 | 5.4 (2.7-11) |
| Tetracycline | 75 (52) | 86 (70) | 0.09 | 2.1 (0.9-4.8) |
| Florfenicol | 14 (10) | 2 (2) | 0.01 | 0.1 (0.03-0.7) |
| Chloramphenicol | 39 (27) | 58 (47) | 0.02 | 2.2 (1.1-4.1) |
| Colistin† | 0 (0) | 0 (0) | - | - |
| Sulfamethoxazole | 61 (42) | 84 (68) | 0.002 | 3.4 (1.6-7.2) |
| Trimethoprim | 42 (29) | 70 (57) | <0.001 | 3.3 (1.7-6.4) |
| Ampicillin† | 70 (48) | 85 (69) | 0.02 | 2.5 (1.1-5.6) |
| Cefotaxime† | 1 (1) | 1 (1) | 0.9 | |
| Ceftazidime† | 4 (3) | 4 (3) | 0.8 | |
| Multidrug-resistanceb | 74 (51) | 89 (72) | 0.002 | 3.7 (1.2-8.8) |
†Antimicrobial classified as critically important for human medicine according to WHO [22]
aFor the OR estimates, the small-scale farms were used as reference variable and GEE models were used to account for clustering of isolates within farms
bMultidrug-resistance defined as an isolate resistant against at least three different categories of the antimicrobial agents tested